Next Article in Journal
Qualitative Analysis of Primary Care Provider Prescribing Decisions for Urinary Tract Infections
Next Article in Special Issue
Regulation of Geldanamycin Biosynthesis by Cluster-Situated Transcription Factors and the Master Regulator PhoP
Previous Article in Journal
A Topical Desiccant Agent in Association with Manual Debridement in the Initial Treatment of Peri-Implant Mucositis: A Clinical and Microbiological Pilot Study
Previous Article in Special Issue
The Link between Purine Metabolism and Production of Antibiotics in Streptomyces
 
 
Review
Peer-Review Record

Dissolution of the Disparate: Co-ordinate Regulation in Antibiotic Biosynthesis

Antibiotics 2019, 8(2), 83; https://doi.org/10.3390/antibiotics8020083
by Thomas C. McLean 1, Barrie Wilkinson 2,*, Matthew I. Hutchings 1,* and Rebecca Devine 1
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Reviewer 3: Anonymous
Antibiotics 2019, 8(2), 83; https://doi.org/10.3390/antibiotics8020083
Submission received: 31 May 2019 / Revised: 10 June 2019 / Accepted: 14 June 2019 / Published: 18 June 2019
(This article belongs to the Special Issue Mechanism and Regulation of Antibiotic Synthesis in Streptomyces)

Round 1

Reviewer 1 Report

This is a nice review on the regulation of secondary metabolites biosynthesis focusing on examples of cross-cluster regulation. The review is concise, is well written, and the examples described are appropiately referenced. I thus recommend the acceptance of the draft in its current form.


Minor comments: Many CSRs seem to regulate more than one BGC, thus making the division between these CSR and global regulators somewhat blurred. Could these CSRs that exert control in the biosynthesis of more than one BGC be considered global regulators that happen to be encoded within the boundaries of one of the biosynthetic BGC? Or do the authors consider that there are significant differences between global regulatos and cross-cluster CSRs? Would a brief discussion on this subject be relevant in the final part of the manuscript?


Author Response

>We think there are significant differences, global regulators control many different genes not just BGCs but we have added a line to clarify this. 


Reviewer 2 Report

Antibiotic resistance is a major challenge in healthcare these days so understanding their mechanism and studying the biosynthesis pathways to discover new natural antibiotic has become necessary to combat emerging resistance.

I find this review very interesting and relevant to understand the mechanism of antibiotic bio-synthetic pathways in antibiotic producing microorganism, their metabolites and regulatory systems. Its written well and it will definitely interest to the readers. I recommend this review to be published in antibiotics.

As a suggestion, I would like to add that if authors could represent some of the pathways and mechanism by schematic representation, it will make it more attractive and much easier for readers to understand, especially for those who are involved in interdisciplinary research.

Author Response

>We did attempt this but it was actually more confusing than leaving it out so we decided to add the schematic (Fig 1) instead. 


Reviewer 3 Report

The manuscript is well organized and written.


The manuscript by McLean and colleagues, entitled "Dissolution of the disparate: co-ordinate regulation in antibiotic biosynthesis"  is focused on the review of regulators found associated with the control of expression of genes involved in antibiotics biosynthesis. Global regulators as well as regulators associated with the control of 2 antibiotic gene clusters are thoroughly reviewed throughout the manuscript. Emphasis is given by authors to regulators that are involved in the the regulation of multiple antibiotic operons. The authors claim the importance of this knowledge in order manipulate the expression of silent operons, and how this will lead in the future to the discovery of novel antibiotics. 

The work is well organized and written. I have only a few minor comments to the manuscript.

line 79: explain the abbreviations PKS and NRPS

line 95: "encodes for proteins involved in the biosynthsis..."

line 265: "anti-fungal activity was detected..."

line 335: synthesize

line 406: "binding sites in E. coli....". do the authors mean DNA binding sites? Please clarify.

Author Response

line 79: explain the abbreviations PKS and NRPS

>Changed

line 95: "encodes for proteins involved in the biosynthsis..."

>Changed

line 265: "anti-fungal activity was detected..."

>Changed

line 335: synthesize

>Changed

line 406: "binding sites in E. coli....". do the authors mean DNA binding sites? Please clarify.

>Yes, we have made this clear

 

 

 


Author Response File: Author Response.docx

Back to TopTop